Skip label
Find side effects reporting information at the bottom of this page 
If you are a UK Healthcare Professional, please visit our Healthcare Professional website here
This website is for UK members of the public, patients prescribed Boehringer Ingelheim medicines and their carers.

Metalyse® 25mg (tenecteplase) for the treatment of Acute Ischaemic Stroke

This page is intended to provide reference information for UK members of the public, patients prescribed Metalyse 25mg (tenecteplase) and their carers. This information is not intended to replace the advice of a healthcare professional.

Patient Information Leaflet

The Patient Information Leaflet is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using this medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Summary of Product Characteristics

The Summary of Product Characteristics (SmPC) tells healthcare professionals, such as doctors, pharmacists and nurses, how to prescribe and use this medicine correctly. The information in the Patient Information Leaflet and Summary of Product Characteristics are not intended to replace the advice of a healthcare professional.

Public Assessment Report

The public assessment report (PAR) provides public information on how the medicine was assessed by MHRA.

NP-GB-104993 | December 2024

picture of man typing on laptop

Side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any side effects not listed in package leaflet.
You can also report side effects directly to the Yellow Card scheme
of www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of the medicine.